Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Not All Infectious Microorganisms Malign Human Immune System

Simon M. Helfgott, MD  |  Issue: November 2016  |  November 16, 2016

The test was worth every penny; the genetic interrogation coaxed the excised heart valve to confess to having been infected with Tropheryma whipplei, that wily and elusive organism best known as the causative agent for the nasty imitator of rheumatologic illness, Whipple’s disease. So much for a prior diagnosis of seronegative RA, which eventually disappeared along with many of his other symptoms following a change in his antibiotic regimen. MDS has helped identify an infectious cause in many cases of meningoencephalitis and uveitis in a timely fashion.14 Long-term harm can be averted. No doubt, we may be hearing more about its potential utility in determining the cause of cerebritis in those situations when the differential diagnosis includes such conditions as Behçet’s disease, lupus or vasculitis.

Hindsight

Many years ago, I was interviewing for a junior faculty position when I was taken aback by the questioning of the interviewer, who wondered aloud why I considered my five years toiling in a laboratory studying immune mechanisms in RA to be a fruitful use of my time. “You would have been better off studying microbiology” was his retort to the look of consternation spreading across on my face. For years, I considered this to have been a flippant remark. Now, I am not so sure.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Simon M. Helfgott, MDSimon M. Helfgott, MD, is associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School in Boston.

References

  1. Hair M, Sharpe J (eds). Fast facts about the human microbiome. Center for Ecogenetics & Environmental Health. 2014 Jan.
  2. Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol. 2016 Aug;12(8):446–455.
  3. Rascovan N, Duraisamy R, Desnues, C. Metagenomics and the human virome in asymptomatic individuals. Annu Rev Microbiol. 2016 Sep 8;(70):125–141.
  4. Agnello V, Koffler D, Eisenberg JW, et al. C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: Characterization of high and low molecular weight types. J Exp Med. 1971 Sep 1;134(3):228–241.
  5. Agnello V. The Kunkel legacy and hepatitis C virus infection. Clin Immunol. 2016 Aug 6. pii: S1521-6616(16)30228-5. doi: 10.1016/j.clim.2016.07.023. [Epub ahead of print].
  6. Amlie-Lefond C, Gilden D. Varicella zoster virus: A common cause of stroke in children and adults. J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1561–1569.
  7. Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015 May 12;84(19):1948–1955.
  8. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. [article in Japanese]. Arerugi. 1967 Mar;16(3):178–222.
  9. Frazer J. Infectious disease: Blowing in the wind. Nature. 2012 Apr 4;484(7392):21–23.
  10. Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology. 2005 Mar;16(2):220–225.
  11. Rodó X, Ballester J, Cayan D, et al. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep. 2011;1:152–158.
  12. Wei K. Personal communication.
  13. Wilson MR, Shanbhag NM, Reid MJ, et al. Diagnosing balamuthia mandrillaris encephalitis with metagenomic deep sequencing. Ann Neurol. 2015 Nov;78(5):722–730.
  14. Wilson MR, Naccache SN, Samayoa, E et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014 Jun 19;370(25):2408–2417.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:autoimmunityDiseaseessential mixed cryoglobulinemiaHepatitis C virushuman microbiomeImmune SystemInfectionmicroorganism

Related Articles
    Dr. Kawasaki

    Tomisaku Kawasaki, Pediatrician Who Discovered Disease That Bears His Name, Dies at 95

    June 18, 2020

    Japanese pediatrician Tomisaku Kawasaki, MD, who identified an inflammatory syndrome that affects children, died on June 5 in Tokyo. He was 95. Tenacity & Attention to Detail Born Feb. 7, 1925, in Tokyo, Dr. Kawasaki graduated from medical school at what is now Chiba University in Chiba, Japan, in 1948 and worked as staff pediatrician…

    MIA Studio / shutterstock.com

    Kawasaki Guideline Urges Treatment Intensification for Some Patients

    December 16, 2021

    A soon-to-be published guideline from the ACR and the Vasculitis Foundation on Kawasaki disease underscores the importance of early diagnosis and intensified treatment for people with this serious condition.1 Intravenous immunoglobulin (IVIG) remains the treatment mainstay, and prompt, aggressive treatment may be able to reduce the risk of serious complications in some patients. The guideline…

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Thinking Big, Thinking Small

    June 17, 2019

    I would like to tell you a story. Two, actually. I am just returning from the 19th International Vasculitis and ANCA Workshop, which is always a fascinating meeting. In its inception, it was a workshop, in the true sense of the word. Now, we discuss anti-neutrophil cytoplasmic antibody (ANCA) testing as casually as we discuss…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences